Ann: Quarterly Results and Investor Conference Call Notification, page-22

Hey theoc,

Nice to have you post.

A lot of ground to cover from your question, but if we're talking purely the Dx app (for pneumonia etc...), it depends on the agreement between ResApp and the provider (i.e. Medgate, Alodokter, Coviu etc).

With Medgate and Alodokter, I believe it is a tiered subscription basis, so Medgate and Alo will pay RAP a certain figure each month for a number of uses. If the uses exceed that tier (Example 10,000 uses is tier 1, 10,001 + is tier 2), they'll pay a different figure, presumably higher.

Does that answer the basic question? A lot of others better at explaining stuff may be able to answer as well.